Allspring Global Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
VPM
VCM
Allspring Global Investments's IRWD Position: Q1 2026 in Review
Allspring Global Investments opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 79,193 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #1519 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in IRWD as recently as Q1 2025.
Allspring Global Investments first reported a position in IRWD in Q4 2021 and has held it in 15 quarters since. The position peaked at $11.9M in Q1 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Allspring Global Investments held 79,193 shares of Ironwood Pharmaceuticals worth $309K as of Q1 2026.
- Ironwood Pharmaceuticals was a new Allspring Global Investments position in Q1 2026.
- Ironwood Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1519 holding.
- Allspring Global Investments first reported a position in Ironwood Pharmaceuticals in Q4 2021 and has held it in 15 quarters since.
- Allspring Global Investments's Ironwood Pharmaceuticals position peaked at $11.9M in Q1 2022.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.